Financial Statistical Journal

Submit Papers
Apply for Section Collection

Quantitative Finance

Submission deadline: 2023-12-31
Section Editors

Section Collection Information

Dear Colleagues, 

Quantitative approaches have increasingly been adopted in the field of finance in recent years. This section welcomes original research about interrelationships in Finance, Accounting, Economics and Quantitative methods. Further to conventional high-quality, theoretical, and empirical studies in Finance, this section publishes work involving interdisciplinary emphasis. Papers that focus on theoretical and methodological research engaging real-world applications will be published.   


Keywords

Quantitative Research; Financialization; Digital Finance and Risk Management; Financial and Economic Theory; Financial Markets; Financial Regulation; Behavioral Finance; Corporate Finance; Financial Econometrics; Derivatives pricing and hedging; Financial Trading; Portfolio Management; Asset Pricing; Green Finance; Sustainability Accounting; Nonlinear and stochastic optimization in finance.

Published Paper

Immunotherapy for triple-negative breast cancer

Xiaosheng Wang;Yin He;

Targeting the ACE2 receptor using nanomedicine: Novel approach to lung cancer therapy

Moganavelli Singh;Dillon Sivalingam;
The angiotensin-converting enzyme 2 (ACE2) receptor gained prominence in 2020, having been identified as a prime receptor for entry of the novel coronavirus COVID-19, which has led to the current global pandemic. Many stud-ies have reported that lung cancer patients have a higher risk of contracting COVID-19 due to the up-regulated expres-sion of ACE2 in lung cancer cells. Lung cancer is a heterogeneous disease and the most frequently occurring cancer globally. It is more prevalent in men than in women and accounts for an estimated 40% of cancer cases. Over the years, many studies have reported on the ACE2 expression in lung cancer. Conventional methods currently available for the detection and treatment of lung cancer face numerous challenges. Nanomedicine has risen to many challenges facing cancer therapy and drug delivery. With the array of nano delivery systems available, nanomedicine can be used to de-velop alternative methods to help overcome these challenges and improve the therapeutic efficiency in cancer therapy. Hence, this review focuses on lung cancer, the ACE2 receptor, and the use of nanomedicine in formulating a novel tar-geted cancer treatment strategy directed at the ACE2 receptor. This may serve as a stepping stone for exploring further targeting strategies and therapies.

Frequency and clinicopathologic associations of microsatellite instability and PD-L1 expression in Vietnamese patients with gastric cancer

Pham Van Thinh;Tran Ngoc Dung;Vi Thuat Thang;Nguyen Thanh Chung;Nguyen Thuy Linh;Nguyen Thu Hien;Truong Dinh Tien;Dang Son Tung;Dang Thai Tra;Nguyen Mai Hanh;Kieu Van Khuong;Pham Xuan Huy;Nguyen Van De;Dang Thanh Chung;

Assessment of PD-L 1 expression in a tumor improves the accuracy of predicting the risk of regional breast cancer metastases

Evgenia Zubareva;Marina Senchukova;Dmitriy Shubin;Alexander Prokofiev;






EnPress Publisher LLC. 9650 Telstar Avenue，Unit A，Suit 121，El Monte，CA 91731, USA.
Tel:2312398888